2014

Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps

PARSIPPANY, N.J., Jan. 8, 2012 /PRNewswire/ -- Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin® and NoDoz® products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States. NCH is taking this action as a precautionary measure because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets.

The affected bottle sizes are attached to this release. The Novartis Consumer Health Inc. Lincoln, NE facility has voluntarily suspended operations and shipments to accelerate maintenance and other improvement activities at the site.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Mixing of different products in the same bottle could result in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient. This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient. NCH is not aware of adverse events reported with the issues leading to the recall.

These over-the-counter products were distributed nationwide to wholesalers and retailers.

Novartis Consumer Health Inc. is notifying its distributors and customers and is arranging for return of all recalled products. Wholesalers and retailers should stop distribution and return the affected product using Novartis Product Return information that is being provided to them.

Consumers that have the product(s) being recalled should stop using the product(s) and contact the Novartis Consumer Relationship Center at 1-888-477-2403 (available Monday-Friday 9 a.m. to 8 p.m. Eastern Time) for information on how to return the affected products and receive a full refund. For more detailed information, consumers should visit our website at www.novartisOTC.com as of January 9, 2012. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Adverse events that may be related to the use of these products may be reported to FDA's MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

These actions announced today, highlight the strong Novartis commitment to a single quality standard for the Novartis Group. The Novartis Group is making the necessary investments and committing the right resources to ensure these are implemented across the entire Novartis Group network. The high quality of Novartis products and operations has been critical to building the Novartis Group reputation over the past 15 years. Novartis Group is committed to ensuring the highest standard for patients who rely on our products and medicines.

Novartis Consumer Health Inc. plans to gradually resume operations at its Lincoln, NE site following implementation of planned improvements and in agreement with the FDA. The Novartis Consumer Health Inc. Lincoln, NE facility produces a variety of products mainly for the US market with annual sales value of less than 2% of Novartis Group sales. At this stage, it is not possible to determine when the plant will resume full operations and the full financial impact of these events. NCH will take a one-time charge currently estimated at USD 120 million in the fourth quarter of 2011, relating to the recalls and improvement work at the Lincoln, NE facility.

Novartis commitment to quality

The Novartis Group is fully committed to ensuring the quality, safety and integrity of its products. All Novartis Group companies have a clear commitment to patients and Health Authorities to ensure high quality standards for all our products and services. Novartis Group companies stand behind the safety and efficacy of their products, and are fully committed to maintaining high quality standards at all production sites in the US and around the world. All Novartis Group products are subjected to strict manufacturing, testing and monitoring standards. Where they fall outside the standards, Novartis Group companies take actions to correct the issue and may recall products as a precaution.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "potential," "will," "committed," "commitment," "plans," or similar expressions, or by express or implied discussions regarding the potential length of the shutdown of our Lincoln, NE production facility, regarding the potential for any further regulatory actions at the Lincoln, NE production facility, regarding the potential for any further quality issues arising at any additional Novartis manufacturing facilities, or regarding the potential financial impact of the Lincoln, NE facility shutdown. You should not place undue reliance on these statements.  Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that our Lincoln, NE production facility will reopen at any particular time. Nor can there be any guarantee that actions described in this release will be the only regulatory actions required at the Lincoln, NE facility.  Neither can there be any guarantee that further quality issues will not arise at any additional Novartis Group manufacturing facilities.  Nor can there be any guarantee as to the potential financial impact on Novartis resulting from the shutdown of the Lincoln, NE production facility. In particular, management's expectations could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected manufacturing issues, including unexpected inabilities to satisfy regulators' requirements for the reopening of the Lincoln, NE production facility; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Group provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 121,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

Novartis Media Relations

 

 

Julie Masow

Novartis Corporation

+1 212 830 2465 (direct)

+1 862 579 8456 (mobile)

julie.masow@novartis.com

 

Pamela McKinlay

Novartis Consumer Health, Inc.

+1 973 503 7337(direct)

+1 862 221 0151(mobile)

pamela.mckinlay@novartis.com

 

e-mail: us.mediarelations@novartis.com

Milicent Brooks

Novartis Consumer Health, Inc.

+1 973 503 7483(direct)

+1 973 479 2078 (mobile)

milicent.brooks@novartis.com

 

For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.

Material

Material description

UPC Code

UCC Code

NDC Code

Quantity Returned

100007332

Bufferin® Extra Strength Tablets 130CT 

300672065131

10300672065138

0067206513

 

100007330

Bufferin® Extra Strength Tablets 39CT 

300672065391

10300672065398

0067206539

 

100007776

Bufferin® Low Dose Tablets 130CT

300676424132

10300676424139

0067642413

 

100007345

Bufferin® Regular Strength Tablets 130CT 

300672063137

10300672063134

0067206313

 

100008631

Excedrin® Back & Body Caplets 100CT Account Specific

300676238920

10300676238927

0067623891

 

100008076

Excedrin® Back & Body Caplets 100CT Account Specific No Carton

300676238944

10300676238941

0067623894

 

100008075

Excedrin® Back & Body Caplets 100CT New Label

300676238913

10300676238910

0067623891

 

100008073

Excedrin® Back & Body Caplets 24CT New Label

300676238241

10300676238248

0067623824

 

100008074

Excedrin® Back & Body Caplets 50CT New Label

300676238500

10300676238507

0067623850

 

100008627

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000927

10300672000924

0067200091

 

100005995

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000941

10300672000948

0067200094

 

100008027

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000941

10300672000948

0067200094

 

100008026

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000910

10300672000917

0067200091

 

100003160

Excedrin® Extra Strength Caplets 100CT

300672000910

10300672000917

0067200091

 

100007201

Excedrin® Extra Strength Caplets 125CT Bonus Pack

300672000835

10300672000832

0067200083

 

100008434

Excedrin® Extra Strength Caplets 125CT Bonus Pack Account Specific

300672000842

10300672000849

0067200084

 

100008455

Excedrin® Extra Strength Caplets 125CT New Carton

300672000866

10300672000863

0067200086

 

100009008

Excedrin® Extra Strength  Caplets 24+6CT Bonus Pack

300672000309

10300672000306

0067200030

 

100003157

Excedrin® Extra Strength  Caplets 24CT

300672000248

10300672000245

0067200024

 

100008024

Excedrin® Extra Strength  Caplets 24CT New Label

300672000248

10300672000245

0067200024

 

100004485

Excedrin® Extra Strength  Caplets 250CT No Carton

300672000071

10300672000078

0067200007

 

100008033

Excedrin® Extra Strength  Caplets 250CT No Carton New Label

300672000071

10300672000078

0067200007

 

100004868

Excedrin® Extra Strength  Caplets 250CT Special Inner

300672000774

10300672000771

0067200077

 

100008029

Excedrin® Extra Strength  Caplets 250CT New Label

300672000774

10300672000771

0067200077

 

100008635

Excedrin® Extra Strength  Caplets 300CT Bonus Pack

300672000552

10300672000559

0067200055

 

100008025

Excedrin® Extra Strength  Caplets 50CT New Label

300672000507

10300672000504

0067200050

 

100003158

Excedrin® Extra Strength  Caplets 50S

300672000507

10300672000504

0067200050

 

100007982

Excedrin® Extra Strength  Express Gel Caps 20CT New Label

300676270203

10300676270200

0067627020

 

100007987

Excedrin® Extra Strength  Express Gel Caps 40CT New Label

300676270401

10300676270408

0067627040

 

100008630

Excedrin® Extra Strength  Express Gel Caps 80CT Account Specific

300676270814

10300676270811

0067627080

 

100007988

Excedrin® Extra Strength  Express Gel Caps 80CT 

300676270807

10300676270804

0067627080

 

100007989

Excedrin® Extra Strength  Express Gel Caps 80CT Account Specific

300676270944

10300676270941

0067627094

 

100008037

Excedrin® Extra Strength  Gel Tablets 24CT 

300672021243

10300672021240

0067202124

 

100004674

Excedrin® Extra Strength  Tablets 100CT Special Inner

300672030917

10300672030914

0067203091

 

100008626

Excedrin® Extra Strength  Tablets 100CT Account Specific

300672030931

10300672030938

0067203091

 

100008016

Excedrin® Extra Strength  Tablets 100CT Account Specific

300672030948

10300672030945

0067203094

 

100008010

Excedrin® Extra Strength  Tablets 100CT New Label

300672030917

10300672030914

0067203091

 

100007200

Excedrin® Extra Strength  Tablets 125CT Bonus Pack

300672030832

10300672030839

0067203083

 

100008460

Excedrin® Extra Strength  Tablets 125CT Bonus Pack New Carton

300672030863

10300672030860

0067203086

 

100008022

Excedrin® Extra Strength  Tablets 200CT New Label

300672030924

10300672030921

0067203092

 

100009062

Excedrin® Extra Strength  Tablets 24+6CT Bonus Pack

300672030306

10300672030303

0067203030

 

100003181

Excedrin® Extra Strength  Tablets 24CT

300672030245

10300672030242

0067203024

 

100008008

Excedrin® Extra Strength  Tablets 24CT New Label

300672030245

10300672030242

0067203024

 

100008807

Excedrin® Extra Strength  Tablets 250+50CT Bonus Pack 

300672030573

10300672030570

0067203055

 

100004173

Excedrin® Extra Strength  Tablets 250CT No Carton

300672030078

10300672030075

0067203007

 

100008031

Excedrin® Extra Strength  Tablets 250CT No Carton New Label

300672030078

10300672030075

0067203007

 

100004869

Excedrin® Extra Strength  Tablets 250CT Special Inners

300672030771

10300672030778

0067203077

 

100008019

Excedrin® Extra Strength  Tablets 250CT New Label

300672030771

10300672030778

0067203077

 

100007470

Excedrin® Extra Strength  Tablets 300CT New Carton

300672030337

10300672030310

0067203033

 

100008472

Excedrin® Extra Strength  Tablets 300CT Club Tray

300672030337

10300672030310

0067203033

 

100008020

Excedrin® Extra Strength  Tablets 300CT New Label

300672030337

10300672030310

0067203033

 

100003134

Excedrin® Extra Strength  Tablets 300S

300672030337

10300672030334

0067203033

 

100003186

Excedrin® Extra Strength  Tablets 50CT

300672030504

10300672030501

0067203050

 

100008009

Excedrin® Extra Strength  Tablets 50CT New Label

300672030504

10300672030501

0067203050

 

100006967

Excedrin® Extra Strength  Tablets 8CT

300672030085

10300672030082

0067203008

 

100008007

Excedrin® Extra Strength  Tablets 8CT New Label

300672030085

10300672030082

0067203008

 

100007967

Excedrin® Migraine  Express Gel Caplets 20CT New Label

300676341200

10300676341207

0067634120

 

100003178

Excedrin® Migraine Caplets 100CT

300672039910

10300672039917

0067203991

 

100005998

Excedrin® Migraine Caplets 100CT Account Specific

300672039941

10300672039948

0067203994

 

100008087

Excedrin® Migraine Caplets 100CT Account Specific No Carton

300672039941

10300672039948

0067203994

 

100008656

Excedrin® Migraine Caplets 100CT Account Specific

300672043917

10300672043914

0067203991

 

100008086

Excedrin® Migraine Caplets 100CT New Label

300672039910

10300672039917

0067203991

 

100008443

Excedrin® Migraine Caplets 125CT Bonus Pack No Carton

300672039842

10300672039849

0067203984

 

100008461

Excedrin® Migraine Caplets 125CT Bonus Pack New Carton

300672039866

10300672039863

0067203986

 

100007215

Excedrin® Migraine Caplets 125CT Bonus Pack

300672039835

10300672039832

0067203983

 

100008090

Excedrin® Migraine Caplets 200CT New Label

300672039927

10300672039924

0067203992

 

100009016

Excedrin® Migraine Caplets 24+6CT Bonus Pack

300672039309

10300672039306

0067203930

 

100003182

Excedrin® Migraine Caplets 24CT

300672039248

10300672039245

0067203924

 

100008084

Excedrin® Migraine Caplets 24CT New Label

300672039248

10300672039245

0067203924

 

100008809

Excedrin® Migraine Caplets 250+50CT Bonus Pack

300672039576

10300672039573

0067203955

 

100004174

Excedrin® Migraine Caplets 250CT No Carton

300672039071

10300672039078

0067203907

 

100008093

Excedrin® Migraine Caplets 250CT No Carton New Label

300672039071

10300672039078

0067203907

 

100004870

Excedrin® Migraine Caplets 250CT Special Inners

300672039774

10300672039771

0067203977

 

100008091

Excedrin® Migraine Caplets 250CT New Label

300672039774

10300672039771

0067203977

 

100003121

Excedrin® Migraine Caplets 300CT

300672039330

10300672039337

0067203933

 

100007469

Excedrin® Migraine Caplets 300CT New Carton

300672039330

10300672039313

0067203933

 

100008092

Excedrin® Migraine Caplets 300CT New Label

300672039330

10300672039313

0067203933

 

100008471

Excedrin® Migraine Caplets 300CT Club Tray

300672039330

10300672039313

0067203933

 

100008085

Excedrin® Migraine Caplets 50CT New Label

300672039507

10300672039504

0067203950

 

100003185

Excedrin® Migraine Caplets 50CT 

300672039507

10300672039504

0067203950

 

100008079

Excedrin® Migraine Caplets 8CT New Label

300672039088

10300672039085

0067203908

 

100008015

Excedrin® Migraine Gel  Tablets 160CT

300672035165

10300672035162

0067203516

 

100004681

Excedrin® Migraine Gel Tablets 100CT Special Inner

300672035912

10300672035919

0067203591

 

100008096

Excedrin® Migraine Gel Tablets 100CT New Label

300672035912

10300672035919

0067203591

 

100008657

Excedrin® Migraine Gel Tablets 100CT Account Specific

300672044914

10300672044911

0067203591

 

100008094

Excedrin® Migraine Gel Tablets 24CT - New Label

300672035240

10300672035247

0067203524

 

100008819

Excedrin® Migraine Gel Tablets 2X50CT

300672035936

10300672035933

0067203593

 

100008095

Excedrin® Migraine Gel Tablets 50CT New Label

300672035509

10300672035506

0067203550

 

100004675

Excedrin® Migraine Tablets 100CT Special Inner

300672037916

10300672037913

0067203791

 

100008082

Excedrin® Migraine Tablets 100CT New Label

300672037916

10300672037913

0067203791

 

100008437

Excedrin® Migraine Tablets 125CT Bonus Pack

300672037831

10300672037838

0067203783

 

100009094

Excedrin® Migraine Tablets 24+6CT Bonus Pack

300672037305

10300672037302

0067203730

 

100003174

Excedrin® Migraine Tablets 24CT

300672037244

10300672037241

0067203724

 

100008080

Excedrin® Migraine Tablets 24CT New Label

300672037244

10300672037241

0067203724

 

100004872

Excedrin® Migraine Tablets 250CT Special Inner

300672037770

10300672037777

0067203777

 

100008083

Excedrin® Migraine Tablets 250CT New Label

300672037770

10300672037777

0067203777

 

100003173

Excedrin® Migraine Tablets 50CT

300672037503

10300672037500

0067203750

 

100008081

Excedrin® Migraine Tablets 50CT New Label

300672037503

10300672037500

0067203750

 

100008049

Excedrin® PM Caplets 100CT New Label

300672055910

10300672055917

0067205591

 

100008459

Excedrin® PM Caplets 125CT Bonus Pack New Carton

300672055866

10300672055863

0067205586

 

100008047

Excedrin® PM Caplets 24CT New Label

300672055248

10300672055245

0067205524

 

100008048

Excedrin® PM Caplets 50CT New Label

300672055507

10300672055504

0067205550

 

100007146

Excedrin® PM Express Gel Caplets 20CT 

300676405209

10300676405206

0067640520

 

100008632

Excedrin® PM Express Gel Caplets 80CT Account Specific

300676405810

10300676405817

0067640580

 

100007202

Excedrin® PM Express Gel Caplets 80CT No Carton

300676409801

10300676409808

0067640980

 

100007148

Excedrin® PM Express Gel Caplets 80CT New Label

300676405803

10300676405800

0067640580

 

100008629

Excedrin® PM Tablets 100CT Account Specific

300672053923

10300672053920

0067205391

 

100008065

Excedrin® PM Tablets 100CT Account Specific No Carton

300672053947

10300672053944

0067205394

 

100008064

Excedrin® PM Tablets 100CT New Label

300672053916

10300672053913

0067205391

 

100008449

Excedrin® PM Tablets 125CT Bonus Pack

300672053831

10300672053838

0067205383

 

100009095

Excedrin® PM Tablets 24+6CT Bonus Pack

300672053305

10300672053302

0067205330

 

100008051

Excedrin® PM Tablets 24CT New Label

300672053244

10300672053241

0067205324

 

100008063

Excedrin® PM Tablets 50CT New Label

300672053503

10300672053500

0067205350

 

100008046

Excedrin® PM Tablets 8CT New Label

300672053084

10300672053081

0067205308

 

100008040

Excedrin® Sinus Headache Caplets 24CT New Label

300672062246

10300672062243

0067206224

 

100004691

Excedrin® Tension Headache Caplets 100CT Special Inner

300672045911

10300672045918

0067204591

 

100006001

Excedrin® Tension Headache Caplets 100CT Account Specific No Carton

300672045942

10300672045949

0067204594

 

100008057

Excedrin® Tension Headache Caplets 100CT Account Specific No Carton New Label

300672045942

10300672045949

0067204594

 

100008628

Excedrin® Tension Headache Caplets 100CT Account Specific 

300672045959

10300672045956

0067204591

 

100008056

Excedrin® Tension Headache Caplets 100CT New Label

300672045911

10300672045918

0067204591

 

100008442

Excedrin® Tension Headache Caplets 125CT Bonus Pack

300672045836

10300672045833

0067204583

 

100008453

Excedrin® Tension Headache Caplets 125CT Bonus Pack No Carton

300672045843

10300672045840

0067204584

 

100009007

Excedrin® Tension Headache Caplets 24+6CT Bonus Pack

300672045300

10300672045307

0067204530

 

100004689

Excedrin® Tension Headache Caplets 24CT Special Inner

300672045249

10300672045246

0067204524

 

100008068

Excedrin® Tension Headache Caplets 24CT New Label

300672045249

10300672045246

0067204524

 

100003209

Excedrin® Tension Headache Caplets 250CT

300672045775

10300672045772

0067204577

 

100004406

Excedrin® Tension Headache Caplets 250CT No Carton

300672045072

10300672045079

0067204507

 

100004690

Excedrin® Tension Headache Caplets 50CT Special Inner

300672045508

10300672045505

0067204550

 

100008069

Excedrin® Tension Headache Caplets 50CT New Label

300672045508

10300672045505

0067204550

 

100007978

Excedrin® Tension Headache Express Gel Caplets 20CT 

300676272207

10300676272204

0067627220

 

100007979

Excedrin® Tension Headache Express Gel Caplets 40CT 

300676272405

10300676272402

0067627240

 

100007981

Excedrin® Tension Headache Express Gel Caplets 80CT Account Specific 

300676272948

10300676272945

0067627294

 

100007980

Excedrin® Tension Headache Express Gel Caplets 80CT 

300676272801

10300676272808

0067627280

 

100008060

Excedrin® Tension Headache Gel Tablets 24CT New Label

300672050243

10300672050240

0067205024

 

100007153

Gas-X® Prevention® Caplets 20CT

300433005208

10300433005205

N/A

 

100007154

Gas-X® Prevention® Caplets 50CT

300433005505

10300433005502

N/A

 

100004719

NoDoz® Maximum Strength Caplets 16CT

300672070166

10300672070163

0067207016

 

100008716

NoDoz® Maximum Strength Caplets 16CT New Graphic

300672070166

10300672070163

0067207016

 

100004720

NoDoz® Maximum Strength Caplets 36CT

300672070364

10300672070361

0067207036

 

100008715

NoDoz® Maximum Strength Caplets 36CT New Graphic

300672070364

10300672070361

0067207036

 

100004721

NoDoz® Maximum Strength Caplets 60CT

300672070609

10300672070606

0067207060

 

100008717

NoDoz® Maximum Strength Caplets 60CT New Graphic

300672070609

10300672070606

0067207060

 

 

SOURCE Novartis Consumer Health, Inc.



RELATED LINKS
http://www.novartis.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.